Salvinorin derivatives and uses thereof

Details Salvinorin derivatives and uses thereof Salvinorin derivatives and uses thereof

2005-03-14

2009-12-08

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07629475

ABSTRACT:
The invention features salvinorin compositions that are selective for kappa opioid receptors; methods of treating mania by using a selective kappa receptor agonist; and methods of treating mood disorders, such as depressive disorders and manic disorders, using salvinorin compositions.

REFERENCES:
patent: 2006/0058264 (2006-03-01), Prisinzano
patent: 2006/0083679 (2006-04-01), Zjawiony et al.
patent: WO 02/49643 (2002-06-01), None
patent: WO 2005/089745 (2005-09-01), None
Siebert et al., Annals of Botany, “Localization of salvinorin A and related compounds in glandular trichomes of the psychoactive sage, salvia divinorum”, 2004, vol. 93, pp. 763-771.
Chavkin et al., Journal of pharmacology and experimental therapeutics, “Salvinorin A, and active component of the hallucinogenic sage salvia divinorum is a highly efficacious K-Opioid receptor agonist: structural and functional considerations”, 2004, vol. 304, pp. 1197-1203.
Bigham et al., Journal of natural products, “Divinatorins A-C, New neoclerodane diterpenoids from the controlled sage salvia divinorum”, 2003, vol. 66, pp. 1242-1244.
Munro et al., Journal of natural products, “Salvinorins D-F, new neoclerodane diterpenoids from salvia divinorum, and an improved method for the isolation of salvinorin A”, 2003, vol. 66, pp. 703-705.
Sheffler et al., Trends in pharmacological sciences, “Salvinorin A: the ‘magic mint’ hallucinogen finds a molecular target in the kappa opioid receptor”, 2003, vol. 24, pp. 107-109.
Roth et al., Proceedings of the national academy of sciences of the united states of america, “Salvinorin A: A potent naturally occurring nonnitrogenous K opioid selective agonist”, 2002, vol. 99, pp. 11934-11939.
Valdes et al., Organic Letters, “Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic mexican mint salvia divinorum”, 2001, vol. 3, pp. 3935-3937.
Giroud et al., Forensic science international, “Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland”, 2000, vol. 112, pp. 143-150.
Koreeda et al., Chemistry Letters, “The absolute stereochemistry of salvinorins”, 1990, vol. 11, pp. 2015-2018.
Bigham et al., “Divinatorins A-C, New Neoclerodane Diterpenoids from the Controlled SageSalvia Divinorum,” J. Nat. Prod. 66: 1242-1244 (2003).
Beguin et al., “Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18),”Biorg Med Chem Lett. 16:4679-4685 (2006).
Beguin et al., “Synthesis and in vitro pharmacological evaluation of salvinorin A analogues modified at C(2),”Bioorg Med Chem Lett. 15:2761-2765 (2005).
Butelman et al., “The Plant-Derived Hallucinogen, Salvinorin A, Produces κ-Opioid Agonist-Like Discriminative Effects in Rhesus Monkeys,”Psychopharmacol. 172:220-224 (2004).
Carlezon et al., Depressive-like effects of the kappa-opiold receptor agonist salvinorin A on behavior and neurochemistry in rats,J Pharmacol Exp Ther. 316:440-447 (2006).
Chavkin et al., “Salvinorin A, An Active component of the Hallucinogenic SageSalvia Divinorumis a Highly Efficaciousκ-Opioid Receptor Agonist: Structural and Functional Considerations,”J. Pharmacol. Exp. Ther. 308: 1197-1203 (2004).
Chupp et al., “Behavior of Benzyl Sulfoxides Toward Acid Chlorides. Useful Departures from the Pummerer Reaction,”J. Org. Chem. 49:4711-4716 (1984).
Giroud et al., “Salvia Divinorum: An Hallucinogenic Mint Which Might Become a New Recreational Drug in Switzerland,”Forensic Sci. Int. 112: 143-150 (2000).
Huang et al., “Comparison of Pharmacological Activities of Buprenorphine and Norbuprenorphine: Norbuprenorphine is a Potent Opioid Agonist,”J. Pharmacol. Exp. Ther. 297:688-695 (2001).
Koreeda et al., “The Absolute Stereochemistry of Salvinorins,”Chem. Lett. 19:2015-2018 (1990).
Lee et al., “Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues,”Bioorg Med Chem Lett. 15:4169-4173 (2005).
Lee et al., “Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues,”Bioorg Med Chem Lett. 15:3744-3747 (2005).
Ma et al., “Dynorphinergic Gaba Neurons are a Target of Both Typical and Atypical Antipsychotic Drugs in the Nucleus Accumbens Shell, Central Amygdaloid Nucleus and Thalamic Central Medial Nucleus,”Neuroscience121:991-998 (2003).
Mague et al., “Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats,”J. Pharmacol. Exp. Ther. 305:323-330 (2003).
McCurdy et al., “Studies Directed Toward Understanding the Opioid Receptor Recognition of Salvinorin A, a Non-Nitrogenous Natural Product with Kappa Opioid Receptor Selectivity,”2003 Narcotics Research Conference, Abstract #28, p. 51.
Munro et al., “8-epi-Salvinorin B: crystal structure and affinity at the kappa opioid receptor,”Beilstein J Org Chem. 3:1-5 (2007).
Munro et al., “Studies Toward the Pharmacophore of Salvinorin A, A Potent Kappa Opioid Receptor Agonist,”J. Med. Chem. 48: 345-348 (2005).
Munro et al., Salvinorins D-F, New Neoclerodane Diterpenoids from the Salvia divinorum, and an Improved Method for the Isolation of Salvinorin A,J. Nat. Prod. 66:703-705 (2003).
Pliakas et al., “Altered Responsiveness to Cocaine and Increased Immobility in the Forced Swim Test Associated with Elevated cAMP Response Element-Binding Protein Expression in Nucleus Accumbens,”J. Neurosci. 21:7397-7403 (2001).
Roth et al., “Salvinorin A: A Potent Naturally Occurring Nonnitrogenous Kappa Opioid Selective Agonist,”Proc. Nat. Acad. Sci. USA99:11934-11939 (2002).
Sheffler et al., “Salvinorin A: The ‘Magic Mint’ Hallucinogen Finds a Molecular Target in the Kappa Opioid Receptor,”Trends Pharm. Sci. 24: 107-109 (2003).
Siebert, Daniel J., “Localization of Salvinorin A and Related Compounds in Glandular Trichomes of the Psychoactive Sage,Salvio divinorum,” Annals of Botany93: 763-771 (2004).
Valdés et al., “Salvinorin C, a New Neoclerodane Diterpene from a Bioactive Fraction of the Hallucinogenic Mexican MintSalvia divinorum,” Org. Lett. 3:3935-3937 (2001).
Valdés et al., “Divinorin A, a Psychotropic Terpenoid, and Divinorin B from the Hallucinogenic Mexican MintSalvia Divinorum,” J. Org. Chem. 49:4716-4720 (1984).
Zdero et al., “Ent-Clerodanes and Other Constituents from BolivianBaccharisspecies,”Phytochem. 28:531-542 (1989).
Zhang et al., “Kappa Agonist Salvinorin A Induced Conditioned Place Aversion in C57BL/6J Mice,”2003 Narcotics Research Conference, Abstract #102, p. 70.
Zhu et al., “Activation of the Cloned Human Kappa Opioid Receptor by Agonists Enhances [35S]GTPγS Binding to Membranes: Determination of Potencies and Efficacies of Ligands,”J. Pharmacol. Exp. Ther. 282:676-684 (1997).
International Search Report for PCT/US05/08603 dated Jun. 16, 2005.
International Preliminary Report on Patentability for PCT/US05/08603 dated Sep. 13, 2006.
Béguin et al., “N-Methylacetamide Analog of Salvinorin A: A Highly Potent and Selective k-Opioid Receptor Agonist with Oral Efficacy,”J. Pharmacol. Exp. Ther, 324(1):188-195 (2008).
Harding et al., “Synthetic Studies of Neoclerodane Diterpenes From Salvia Divinorum: Selective Modification of the Furan Ring,”Bioorg. Med. Chem. Lett. 16:3170-3174 (2006).
Harding et al., “Synthetic Studies of Neoclerodane Diterpenes From Salvia Divinorum: Semisynthesis of Salvinicins A and B and Other Chemical Transformations of Salvinorin A,”J. Nat. Prod. 69(1):107-112 (2006).
Simpson et al., “Synthetic Studies of Neoclerodane Diterpenes from Salvia Divinorum: Preparation and Opioid Recepto

Affiliated with

Also associated with

Rating

Salvinorin derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Salvinorin derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salvinorin derivatives and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4110684